Drug Topics
APRIL 25, 2024
Despite a wealth of knowledge, pharmacists are frequently not consulted as part of the decision-making team in atrial fibrillation management.
STAT
APRIL 25, 2024
Andrew Bowman, a veterinary epidemiologist at Ohio State University, had a hunch. He had been struck by the huge amounts of H5N1 virus he’d seen in milk from cows infected with the bird flu and thought that at least some virus was getting off of farms and going downstream — onto store shelves. He knew the Food and Drug Administration was working on its own national survey of the milk supply.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 25, 2024
A Q&A with Kirollos Hanna, PharmD, director of pharmacy at Minnesota Oncology, on the current and future landscape of bispecific antibodies in myeloma treatment.
Pharmacy Times
APRIL 25, 2024
The findings emphasize a need for guideline-based care delivery for patients with severe asthma, particularly for patients who are facing social disparities within health care.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 25, 2024
Check out these featured Drug Topics expert interviews from April 2024.
The Guardian - Pharmaceutical Industry
APRIL 25, 2024
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies Doctors have for the first time released details of their spending on a major clinical trial, demonstrating that the true cost of developing a medicine may be far less than the billions of dollars claimed by the pharmaceutical industry.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
APRIL 25, 2024
Advances, challenges, and promising innovations emerge.
STAT
APRIL 25, 2024
After stratospheric levels of hype, early evidence may be bringing generative artificial intelligence down to Earth. A series of recent research papers by academic hospitals has revealed significant limitations of large language models (LLMs) in medical settings, undercutting common industry talking points that they will save time and money, and soon liberate clinicians from the drudgery of documentation.
Fierce Healthcare
APRIL 25, 2024
Amae Health launched in January 2022 to improve care for individuals with severe mental illness through a community-based, integrated approach. | Amae Health, which opened its first outpatient clinic in Los Angeles 18 months ago, closed a $15 million series A round to fuel its growth as it plans to open new clinics in four markets.
STAT
APRIL 25, 2024
LONDON — Claire Booth, a gene therapy researcher in London, had hoped that a biotech company would take her team’s work on an experimental medication for an ultra-rare children’s disease and get it to market. It didn’t happen. Now, in an unusual step, the hospital where she works is trying to get the medicine approved on its own.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
APRIL 25, 2024
This year’s event from June 20 to 21, 2024, in Austin, Texas, will offer 4.25 BCOP CE hours.
STAT
APRIL 25, 2024
In my work as a pediatric psychologist, I’ve been seeing a surge in the number of families with transgender or nonbinary children who are moving to Connecticut, where I live and work. In the past month, a real estate agent colleague has worked with 30 families with transgender children who were trying to find homes in central Connecticut, where they could get access to gender-affirming care.
Pharmacy Times
APRIL 25, 2024
The severity of RSV disease among adults further highlights how crucial vaccine polices and recommendations are.
STAT
APRIL 25, 2024
After months of sustained criticism, Vertex Pharmaceuticals reached an agreement to provide a pricey cystic fibrosis treatment in South Africa, but the move prompted a mixed reaction from consumer groups, some of which complained the deal is geared toward people with expensive health coverage. Under the arrangement, the company is making its Trikafta medication available through a government mechanism that allows a medicine that is not registered for sale in the country to be made available to i
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
APRIL 25, 2024
Teladoc acting CEO Mala Murthy sought to assure investors Thursday that the virtual care giant is poised for future growth even as it faces pressure in a saturated telehealth market. | Teladoc acting CEO Mala Murthy sought to assure investors Thursday that the virtual care giant has a sunny outlook for future growth even as it faces pressure in a saturated telehealth market.
STAT
APRIL 25, 2024
Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a big move: a series of three acquisitions totaling $24 billion that would give BMS a new schizophrenia drug, a targeted cancer medicine, and radiopharmaceuticals used to treat cancer. On Thursday, Bristol released first quarter earnings and showed the price for those acquisitions.
Fierce Healthcare
APRIL 25, 2024
Owlet is bringing its infant vitals monitoring product directly to caregivers through a new partnership with popular telehealth engine, Wheel, it announced Thursday. | Parents can now get a prescription for Owlet's FDA-cleared infant monitoring device through its just-launched telehealth platform, BabySat, powered by Wheel. The company intends to safeguard its rapid access prescriptions through a rigorous provider verification process.
Pharmacy Times
APRIL 25, 2024
Naloxone hydrochloride (Amneal Pharmaceuticals Inc) is the generic equivalent to OTC narcan (Emergent).
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
APRIL 25, 2024
A pair of academic studies published this week painted an unflattering picture of the impact of hospital mergers and acquisitions on healthcare prices and regulators' track record of stepping in to | Two academic studies published this week sought to characterize cross-market deals and whether the FTC is taking a strong enough stance on blocking uncompetitive deals.
Drug Topics
APRIL 25, 2024
Amneal Pharmaceuticals said its generic naloxone hydrochloride nasal spray is now available in the US following FDA approval.
Fierce Pharma
APRIL 25, 2024
Merck touted newly approved Winrevair and what the emergence of the potential blockbuster means for the company as it faces the LOE of Keytruda.
Pharmacy Times
APRIL 25, 2024
Dostarlimab plus chemotherapy is the only immuno-oncology-based therapy that showed statistically significant and clinically meaningful survival benefit in the overall patient population.
Fierce Healthcare
APRIL 25, 2024
Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company announced Thursday. | Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company announced on Thursday.
STAT
APRIL 25, 2024
Dear Readers, Please bear with me as I brag about two of STAT’s most accomplished (and humble) reporters: Casey Ross and Bob Herman.
Fierce Pharma
APRIL 25, 2024
Just a few months after laying into CEOs from Bristol Myers Squibb, Merck & Co., and Johnson & Johnson about the high costs of their drugs, Sen. | Just a few months after laying into CEOs from Bristol Myers Squibb, Merck & Co. and Johnson & Johnson about the high costs of their drugs, Sen. Bernie Sanders, I-Vermont, is taking Novo Nordisk to task for allegedly turning its blockbuster GLP-1s Ozempic and Wegovy into “luxury goods.
Pharmacy Times
APRIL 25, 2024
Tune into this episode of “Public Health Matters” to learn about Dr. Pauline K. Long and her entrepreneurship journey, as well as how she creates meaningful impacts on patients in marginalized communities and within public health.
Fierce Pharma
APRIL 25, 2024
After AstraZeneca’s recent acquisitions of various technologies across different therapeutic areas, some investors started to wonder if the British pharma is stretching too thin. | After AstraZeneca’s recent acquisitions of various technologies across different therapeutic areas, some investors started to wonder if the British pharma is stretching too thin.
STAT
APRIL 25, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Here in Chicago, residents are reeling over the removal of the famed rat hole, a rat-shaped indentation on a piece of sidewalk that drew crowds, fans, and even a proposal and a marriage. The need-to-know this morning AstraZeneca reported first-quarter sales and profits that topped analyst estimates, buoyed by its blockb
Drug Topics
APRIL 25, 2024
With expertise through antimicrobial stewardship experience, researchers believe antimicrobial stewardship pharmacists are vital in assisting diagnostic stewardship.
pharmaphorum
APRIL 25, 2024
On today’s podcast, host Jonah Comstock is joined by Dr Amit Etkin, founder and CEO of Alto Neuroscience, a recently IPO'd biotech that wants to bring precision medicine to psychiatry. But what do we mean when we talk about precision, especially in a discipline like mental health that has historically involved a lot of objectivity?
The Checkup by Singlecare
APRIL 25, 2024
Pharmaceuticals have expiration dates. Adderall falls into this category. Labeled as a controlled substance , Adderall contains amphetamine and dextroamphetamine. Both are amphetamine salts that belong to a class of drugs known as central nervous system ( CNS ) stimulants. However, when prescription drugs are in short supply—as with the recent Adderall shortage —many patients who need this stimulant medication may be tempted to take old pills they find, hoping that’s better than nothing.
Fierce Pharma
APRIL 25, 2024
Facing pressure from the Inflation Reduction Act (IRA) and falling sales for CAR-T therapy Abecma, Bristol Myers Squibb CEO Chris Boerner, Ph.D., still says the Breyanzi-maker h | Facing pressure from the Inflation Reduction Act and falling sales for CAR-T therapy Abecma, Bristol Myers Squibb CEO Chris Boerner says the Beyenzi-maker had a "good start" with the first quarter.
Pharmaceutical Commerce
APRIL 25, 2024
The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.
Expert insights. Personalized for you.
211 
Let's personalize your content